Ignite Creation Date:
2024-05-06 @ 12:41 PM
Last Modification Date:
2024-10-26 @ 1:02 PM
Study NCT ID:
NCT03823911
Status:
COMPLETED
Last Update Posted:
2023-05-22
First Post:
2019-01-28
Brief Title:
Cardiovascular Disease in HIV and Hepatitis C Risk Outcomes After Hepatitis C Eradication
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
Cardiovascular Disease in HIV and Hepatitis C Risk Outcomes After Hepatitis C Eradication
Status:
COMPLETED
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CHROME
Brief Summary:
This is an interventional non-randomized controlled prospective study to treat HCV in mono-infected and HIV co-infected individuals and compare cardiovascular risk outcomes to HIV mono-infected controls This pilot study will demonstrate whether functional cure of HCV reduces myocardial injury and risk of cardiovascular disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None